Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer's drug, a key step toward opening insurance coverage to U.S. seniors with early stages of the brain-robbing disease.
Jun 10, 2023
0
48
A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.
Jun 9, 2023
0
2
With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.
Jun 5, 2023
0
2
Medicare will soon cover a new class of Alzheimer's drugs if they receive full approval from the U.S. Food and Drug Administration, with some key limits.
Jun 2, 2023
0
14
Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they're getting the medication, the U.S. Food and Drug Administration warned Tuesday.
May 31, 2023
0
56
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat moderate-to-severe opioid use disorder.
May 31, 2023
0
5
The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused ...
May 31, 2023
0
22
Since its founding in 2016, Elon Musk's neurotechnology company Neuralink has had the ambitious mission to build a next-generation brain implant with at least 100 times more brain connections than devices currently approved ...
May 30, 2023
0
9
The U.S. Food and Drug Administration (FDA) has approved VOWST, a microbiota-based therapeutic to prevent recurrence of C. difficile Infection (CDI) in adults following antibacterial treatment for recurrent CDI (rCDI). The ...
May 26, 2023
0
3
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose.
May 23, 2023
0
2
